Guillain-Barré Syndrome in a COVID-19 Patient: A Case Report and Review of Management Strategies

  • Mostel Z
  • Ayat P
  • Capric V
  • et al.
N/ACitations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Guillain-Barré syndrome (GBS) in an immune mediated disease that affects peripheral nerves with possible life-threatening complications. GBS has multiple subtypes including acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor sensory axonal neuropathy (AMSAN), which can make GBS difficult to diagnose. GBS commonly presents after viral infections such as influenza virus, campylobacter jejuni, and zika virus. GBS commonly presents with a prolonged clinical course leading to increased morbidity among affected patients. It is not surprising that COVID-19 has been connected with multiple cases of GBS, which may alter the recovery course for several patients post-COVID. In this report, we present a case of 69-year-old-female who presented with progressive motor weakness and loss of sensation in her extremities after testing positive for antibodies to COVID-19 one-month prior to presentation. Her presentation and treatment of GBS in the setting of COVID-19 is an example of one of the many COVID-19 complications and sheds light on the prolonged recovery course that we may experience as clinicians in the wake of this pandemic.

Cite

CITATION STYLE

APA

Mostel, Z., Ayat, P., Capric, V., Trimmingham, A., & I. McFarlane, S. (2021). Guillain-Barré Syndrome in a COVID-19 Patient: A Case Report and Review of Management Strategies. American Journal of Medical Case Reports, 9(3), 198–200. https://doi.org/10.12691/ajmcr-9-3-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free